Nebenwirkungen · Odomzo
Odomzo 200 mg hard capsules · Abschnitt 4.8 · PDF-Seite 12
HOS-220647 · Präparat HOS-216640
Laboratory test Frequency all grades 200 mg Haematological parameters Haemoglobin decreased Very common Lymphocyte count decreased Very common Biochemistry parameters Serum creatinine increased Very common Serum creatine phosphokinase (CK) increased Very common Blood glucose increased Very common Lipase increased Very common Alanine amino transaminase (ALT) increased Very common Aspartate amino transaminase (AST) increased Very common Amylase increased Very common * Based on worst laboratory value post-treatment regardless of baseline, grading by CTCAE version 4.03
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2025-11-17T02:00:00Z · SHA-256 0a9a14a7132ae3f6537f7ebb11602e7c6f9a2d121a10122636d1838b4360dd98 · Passage a0fdca8c6df4e3e1dedf514b89798c07cde4ea2960949e0527496d09291f537b · Zeichen 4693–5622 im Abschnitt